Oritavancin

From IDWiki
Revision as of 17:58, 11 August 2019 by Maintenance script (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Oritavancin

Classification

  • Semisynthetic lipoglycopeptide antibiotic with very long half-life

Indications

  • MRSA skin and soft tissue infections

Dosing

  • IV once a week, long-acting

Renal Dosing

  • Not required

Adverse Events